Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2010
06/10/2010US20100143297 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density
06/10/2010US20100143293 T cell activation
06/10/2010US20100143249 Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/09/2010EP2194062A1 Cyclic heptapeptide and use of the same
06/09/2010EP2194054A1 Ligands for G-protein coupled receptors
06/09/2010EP2194049A1 N-oxides of N-phenyl-2-pyrimidine-amine derivatives
06/09/2010EP2194045A1 Substituted pyrazole derivative
06/09/2010EP2194044A1 Quinolone derivative
06/09/2010EP2193808A1 Synergistic combination
06/09/2010EP2193806A1 Agent for promoting corneal endothelial cell adhesion
06/09/2010EP2193805A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same
06/09/2010EP2193793A1 Nerve cell death inhibitor
06/09/2010EP2193791A1 The treatment of respiratory diseases
06/09/2010EP2192924A2 Saccharide-containing protein conjugates and uses thereof
06/09/2010EP1730115B1 5-aminoalkylpyrazole derivatives as pesticidal agents
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010EP1385864B1 Anti-VEGF-2 antibodies
06/09/2010EP1011686B1 Modulation of human mast cell activation
06/09/2010EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis
06/09/2010CN1994289B Application of dibenzocyclootadiene lignans in preparation of tyrosine-inhibiting medicine
06/09/2010CN1956711B Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same
06/09/2010CN1662511B Pharmaceutical salts of reboxetine
06/09/2010CN1646115B Use of SARMS in preparing medicine for treating benign prostate hyperplasia
06/09/2010CN101730691A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
06/09/2010CN101730690A Sulfonamide compound, and crystal thereof
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101723948A C-6 modified indazolylpyrrolotriazines
06/09/2010CN101723936A Kinase suppressor and pharmaceutical application thereof
06/09/2010CN101723921A CaSR antagonist
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101723890A Aryl thiourea and preparation method and application thereof
06/09/2010CN101721676A Gene regulatory peptides
06/09/2010CN101721570A Method for extracting acorus calamus human body massage liquid
06/09/2010CN101721481A Medicine for treating heatstroke
06/09/2010CN101721420A Antishock function of ginsenoside Re
06/09/2010CN101721412A Methods of treating microbial infections in humans and animals
06/09/2010CN101721086A Method for manufacturing silkworm sand pillow
06/09/2010CN101185735B Compound breast-rounding essential oil
06/09/2010CN101181579B Chrysanthemum row containing natural aromatic plant
06/09/2010CN101181576B Jasmine flower strip containing natural aromatic plant
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/09/2010CN101010076B Immune function-improving agent
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732414 cosmetic make-up removing composition; for treating aging, fibroblasts, keratinocytes; particularly hyaluronic acid, proteoglycans
06/08/2010US7732411 Methods of therapy with thrombin derived peptides
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
06/08/2010US7732186 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells
06/08/2010US7731955 Using lactoperoxidase composition as a therapeutic treatment for rheumatoid arthritis, sepsis, myleoma and influenza infection
06/08/2010US7731951 Viruses for the treatment of cellular proliferative disorders
06/08/2010US7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2433453C Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
06/08/2010CA2431983C Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
06/08/2010CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
06/08/2010CA2388063C Cytotoxic agents comprising taxanes and their therapeutic use
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/08/2010CA2368135C Xylo-lna analogues
06/08/2010CA2360590C Solution-based transdermal drug delivery system
06/03/2010WO2010062217A1 Agent for eliminating multidrug resistance
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061907A1 Anti-cancer agent
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061787A1 Beauveriolide having acat-2 inhibitory activity
06/03/2010WO2010061781A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
06/03/2010WO2010060940A2 Hsp90 inhibitors for therapeutic treatment
06/03/2010WO2010012811A3 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
06/03/2010US20100138948 Transgenic plants with controlled distribution of a trait to progeny
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137456 Polysaccharides functionalized by tryptophan derivatives
06/03/2010US20100137423 Antioxidative composition containing acacia bark derivative
06/03/2010US20100137404 Compositions and Methods for Altering Gene Expression
06/03/2010US20100137383 Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents
06/03/2010US20100137357 Compositions and methods for hyperhidrosis
06/03/2010US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
06/03/2010US20100137335 Metabolites of (thio) carbamoyl-cyclohexane derivatives
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137301 Substituted Indolealkanoic Acids
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137256 Device and Method for Treating Human Body
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents
06/03/2010US20100137229 Method Of Enhancing Lysosomal Alpha-Galactosidase A
06/03/2010US20100137225 drug delivery to liver tissue of a complex or conjugate of drug and polypeptide comprising the amino acid sequence of SEQ ID NO:61; biodrug is siRNA molecule
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 1564